Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.20
+8.42 (65.88%)
At close: Mar 6, 2026, 4:00 PM EST
21.16
-0.04 (-0.19%)
After-hours: Mar 6, 2026, 7:58 PM EST
DAWN Stock Forecast
Stock Price Forecast
The 9 analysts that cover DAWN stock have a consensus rating of "Strong Buy" and an average price target of $27.61, which forecasts a 30.24% increase in the stock price over the next year. The lowest target is $21.5 and the highest is $36.
Price Target: $27.61 (+30.24%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for DAWN stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 6 | 6 | 6 | 6 | 5 |
| Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 9 | 9 | 9 | 9 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jones Trading | Jones Trading | Strong Buy → Hold Downgrades $20 → $22 | Strong Buy → Hold | Downgrades | $20 → $22 | +1.42% | Mar 6, 2026 |
| Needham | Needham | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 6, 2026 |
| Wedbush | Wedbush | Buy Maintains $29 → $30 | Buy | Maintains | $29 → $30 | +41.51% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $22 | Strong Buy | Maintains | $25 → $22 | +3.77% | Feb 25, 2026 |
| Needham | Needham | Strong Buy Maintains $18 → $17 | Strong Buy | Maintains | $18 → $17 | -19.81% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
242.84M
from 158.18M
Increased by 53.52%
Revenue Next Year
308.64M
from 242.84M
Increased by 27.10%
EPS This Year
-0.79
from -1.04
EPS Next Year
-0.05
from -0.79
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 283.3M | 389.8M | |||
| Avg | 242.8M | 308.6M | |||
| Low | 182.3M | 240.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 79.1% | 60.5% | |||
| Avg | 53.5% | 27.1% | |||
| Low | 15.2% | -1.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.07 | 0.56 | |||
| Avg | -0.79 | -0.05 | |||
| Low | -1.98 | -0.62 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.